Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study

Transgenic Research

Volumn 18, Issue 4, 2009, Pages 499-512

  Marusic, Carla ^a   Vitale, Alessandro ^b   Pedrazzini, Emanuela ^b   Donini, Marcello ^a   Frigerio, Lorenzo ^c   Bock, Ralph ^d   Dix, Philip J ^e   McCabe, Matthew S ^e   Bellucci, Michele ^f   Benvenuto, Eugenio ^a  

^a ENEA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^f CNR   (Italy)

Author keywords

Heterologous expression systems; HIV; Multi component vaccine; Nef; Plant made pharmaceuticals; Recombinant proteins

Indexed keywords

AGROBACTERIUM; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RHIZOBIUM;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; NEF PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

BIOSYNTHESIS; CLASSIFICATION; GENE VECTOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN STABILITY; REVIEW; RHIZOBIUM; SERODIAGNOSIS; TRANSGENIC PLANT;

GENETIC VECTORS; HIV ANTIBODIES; HIV ANTIGENS; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NEUTRALIZATION TESTS; PLANTS, GENETICALLY MODIFIED; PROTEIN STABILITY; RHIZOBIUM;

EID: 69449107844     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-009-9244-5     Document Type: Review

References (95)

1. Azad AA, Failla P, Lucantoni A, Bentley J, Mardon C, Wolfe A, Fuller K, Hewish D, Sengupta S, Sankovich S, Grgacic E, McPhee D, Macreadie I (1994) Large-scale production and characterization of recombinant human immunodeficiency virus type 1 Nef. J Gen Virol 75:651-655. doi:10.1099/0022-1317-75-3-651
2. Bakker H, Rouwendal GJ, Karnoup AS, Florack DE, Stoopen GM, Helsper JP, van Ree R, van Die I, Bosch D (2006) An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci USA 103:7577-7582. doi:10.1073/pnas.0600879103
3. Barbante A, Irons S, Hawes C, Frigerio L, Vitale A, Pedrazzini E (2008) Anchorage to the cytosolic face of the ER membrane: anew strategy to stabilize a cytosolic recombinant antigen in plants. Plant Biotechnol J 6:560-575. doi:10.1111/j.1467-7652.2008.00342.x
4. Beachy RN, Fitchen JH, Hein MB (1996) Use of plant viruses for delivery of vaccine epitopes. Ann N Y Acad Sci 792:43-49. doi:10.1111/j.1749-6632.1996.tb32489.x
5. Benchabane M, Goulet C, Rivard D, Faye L, Gomord V, Michaud D (2008) Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnol J 6:633-648. doi:10.1111/j.1467-7652.2008.00344.x
6. Bock R (2001) Transgenic chloroplasts in basic research and plant biotechnology. J Mol Biol 312:425-438. doi:10.1006/jmbi.2001.4960
7. Bock R (2007) Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Curr Opin Biotechnol 18:100-106. doi:10.1016/j.copbio.2006.12.001
8. Borgese N, D'Arrigo A, De Silvestris M, Pietrini G (1993) NADH-cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of post-translational targeting to the endoplasmic reticulum. FEBS Lett 325:70-75. doi:10.1016/0014-5793(93)81416-W
9. Borgese N, Colombo S, Pedrazzini E (2003) The tale of tail-anchored proteins: coming from the cytosol and looking for a membrane. J Cell Biol 161:1013-1019. doi:10.1083/jcb.200303069
10. Borgese N, Francolini M, Snapp E (2006) Endoplasmic reticulum architecture: structures in flux. Curr Opin Cell Biol 18:358-364. doi:10.1016/j.ceb.2006.06.008
11. Coleman CE, Herman EM, Takasaki K, Larkins BA (1996) The maize γ-zein sequesters α-zein and stabilizes its accumulation in protein bodies of transgenic tobacco endosperm. Plant Cell 8:2335-2345
12. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401. doi:10.1038/34929
13. Conley AJ, Kessler JA 2nd, Boots LJ, Tung JS, Arnold BA, Keller PM, Shaw AR, Emini EA (1994) Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Proc Natl Acad Sci USA 91:3348-3352. doi:10.1073/pnas.91.8.3348
14. Cooke SJ, Coates K, Barton CH, Biggs TE, Barrett SJ, Cochrane A, Oliver K, McKeating JA, Harris MP, Mann DA (1997) Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis. J Gen Virol 78:381-392
15. Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG, Black A, Passmore D, Moldovan-Loomis C, Srinivasan M, Cuison S, Cardarelli PM, Dickey LF (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24:1591-1597. doi:10.1038/nbt1260
16. Daniell H (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 1:1071-1079. doi:10.1002/biot.200600145
17. de Virgilio M, De Marchis F, Bellucci M, Mainieri D, Rossi M, Benvenuto E, Arcioni S, Vitale A (2008) The human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin. J Exp Bot 59:2815-2829. doi:10.1093/jxb/ern143
18. Denecke J, Botterman J, Deblaere R (1990) Protein secretion in plant cells can occur via a default pathway. Plant Cell 2:51-59
19. Doran PM (2006) Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol 24:426-432. doi:10.1016/j.tibtech.2006.06.012
20. Durrani Z, McInerney TL, McLain L, Jones T, Bellaby T, Brennan FR, Dimmock NJ (1998) Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods 220:93-103. doi:10.1016/S0022-1759(98)00145-8
21. Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC (2008) HIV vaccine research: the way forward. Science 321:530-532. doi:10.1126/science.1161000
22. Floss DM, Sack M, Stadlmann J, Rademacher T, Scheller J, Stöger E, Fischer R, Conrad U (2008) Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol J 6:379-391. doi:10.1111/j.1467-7652.2008.00326.x
23. Frigerio L, Pastres A, Prada A, Vitale A (2001) Influence of KDEL on the fate of trimeric or assembly-defective phaseolin: selective use of an alternative route to vacuoles. Plant Cell 13:1109-1126
24. Fujiyama K, Furukawa A, Katsura A, Misaki R, Omasa T, Seki T (2007) Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta (1, 4)-galactosyltransferase. Biochem Biophys Res Commun 358:85-91. doi:10.1016/j.bbrc.2007.04.054
25. Geli MI, Torren M, Ludevid D (1994) Two structural domains mediate two sequential events in γ-zein targeting: protein endoplasmic reticulum retention and protein body formation. Plant Cell 6:1911-1922
26. Geyer M, Peterlin BM (2001) Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett 496:91-95. doi:10.1016/S0014-5793(01)02394-8
27. Geyer M, Munte CE, Schorr J, Kellner R, Kalbitzer HR (1999) Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J Mol Biol 289:123-138. doi:10.1006/jmbi.1999.2740
28. Geyer M, Fackler OT, Peterlin BM (2001) Structure-function relationships in HIV-1 Nef. EMBO Rep 2:580-585. doi:10.1093/embo-reports/kve141
29. Goepfert PA, Tomaras GD, Horton H, Montefiori D, Ferrari G, Deers M, Voss G, Koutsoukos M, Pedneault L, Vandepapeliere P, McElrath MJ, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Baden LR, Harro C, Evans T (2007) NIAID HIV vaccine trials network. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine 25:510-518. doi:10.1016/j.vaccine.2006.07.050
30. Hiatt A, Cafferkey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76-78. doi:10.1038/342076a0
31. Horn ME, Pappu KM, Bailey MR, Clough RC, Barker M, Jilka JM, Howard JA, Streatfield SJ (2003) Advantageous features of plant-based systems for the development of HIV vaccines. J Drug Target 11:539-545. doi:10.1080/10611860410001669992
32. Jin C, Altmann F, Strasser R, Mach L, Schähs M, Kunert R, Rademacher T, Glössl J, Steinkellner H (2008) A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 18:235-241. doi:10.1093/glycob/cwm137
33. Joelson T, Akerblom L, Oxelfelt P, Strandberg B, Tomenius K, Morris TJ (1997) Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol 78:1213-1217
34. Karasev AV, Foulke S, Wellens C, Rich A, Shon KJ, Zwierzynski I, Hone D, Koprowski H, Reitz M (2005) Plant based HIV-1 vaccine candidate: tat protein produced in spinach. Vaccine 23:1875-1880. doi:10.1016/j.vaccine.2004.11.021
35. Kim TG, Ruprecht R, Langridge WH (2004a) Synthesis and assembly of a cholera toxin B subunit SHIV 89.6p Tat fusion protein in transgenic potato. Protein Expr Purif 35:313-319. doi:10.1016/j.pep.2004.02.007
36. Kim TG, Ruprecht R, Langridge WH (2004b) SIVmac Gag p27 capsid protein gene expression in potato. Protein Expr Purif 36:312-317. doi:10.1016/j.pep.2004.04.015
37. Kim TG, Gruber A, Ruprecht RM, Langridge WH (2004c) Synthesis and assembly of SIVmac Gag p27 capsid protein cholera toxin B subunit fusion protein in transgenic potato. Mol Biotechnol 28:33-40. doi:10.1385/MB:28:1:33
38. Kim TG, Gruber A, Langridge WH (2004d) HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expr Purif 37:196-202. doi:10.1016/j.pep.2004.04.014
39. Kohleisen B, Gaedigk-Nitschko K, Ohlmann M, Götz E, Ostolaza H, Goni FM, Erfle V (1996) Heparin-binding capacity of the HIV-1 NEF-protein allows one-step purification and biochemical characterization. J Virol Methods 60:89-101. doi:10.1016/0166-0934(96)02049-6
40. Koop HU, Herz S, Golds TJ, Nickelsen J (2007) The genetic transformation of plastids. Top Curr Genet 19:457-510. doi:10.1007/4735_2007_0225
41. Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T (1995) Generation and assembly of secretory antibodies in plants. Science 268:716-719. doi:10.1126/science.7732380
42. Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794-805. doi:10.1038/nrg1177
43. Ma JK, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM (2005) Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6:593-599. doi:10.1038/sj.embor.7400470
44. Macreadie IG, Fernley R, Castelli LA, Lucantoni A, White J, Azad A (1998) Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J Biomed Sci 5:203-210
45. Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F (2007) Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection. J Med Primatol 36:180-194. doi:10.1111/j.1600-0684.2007.00236.x
46. Mainieri D, Rossi M, Archinti M, Bellucci M, De Marchis F, Vavassori S, Pompa A, Arcioni S, Vitale A (2004) Zeolin A new recombinant storage protein constructed using maize γ-zein and bean phaseolin. Plant Physiol 136:3447-3456. doi:10.1104/pp.104.046409
47. Maliga P (2004) Plastid transformation in higher plants. Annu Rev Plant Biol 55:289-313. doi:10.1146/annurev.arplant.55.031903.141633
48. Marusic C, Rizza P, Lattanzi L, Mancini C, Spada M, Belardelli F, Benvenuto E, Capone I (2001) Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75:8434-8439. doi:10.1128/JVI.75.18.8434-8439.2001
49. Marusic C, Nuttall J, Buriani G, Lico C, Lombardi R, Baschieri S, Benvenuto E, Frigerio L (2007) Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells. BMC Biotechnol 7:12. doi:10.1186/1472-6750-7-12
50. Matoba N, Magérus A, Geyer BC, Zhang Y, Muralidharan M, Alfsen A, Arntzen CJ, Bomsel M, Mor TS (2004) A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci USA 101:13584-13589. doi:10.1073/pnas.0405297101
51. McCabe MS, Klaas M, Gonzalez-Rabade N, Poage M, Badillo-Corona J, Zhou F, Karcher D, Bock R, Gray JC, Dix PJ (2008) Plastid transformation of high biomass tobacco variety Maryland Mammoth for production of HIV-1 p24 antigen. Plant Biotech J 6:914-929. doi:10.1111/j.1467-7652.2008.00365.x
52. McInerney TL, Brennan FR, Jones TD, Dimmock NJ (1999) Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. Vaccine 17:1359-1368. doi:10.1016/S0264-410X(98)00388-0
53. McLain L, Porta C, Lomonossoff GP, Durrani Z, Dimmock NJ (1995) Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retroviruses 11:327-334
54. McLain L, Durrani Z, Wisniewski LA, Porta C, Lomonossoff GP, Dimmock NJ (1996) Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14:799-810. doi:10.1016/0264-410X(95)00229-T
55. Meyers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Williamson AL, Rybicki EP (2008) Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol 8:53. doi:10.1186/1472-6750-8-53
56. Obregon P, Chargelegue D, Drake PM, Prada A, Nuttall J, Frigerio L, Ma JK (2006) HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J 4:195-207. doi:10.1111/j.1467-7652.2005.00171.x
57. Oey M, Lohse M, Kreikemeyer B, Bock R (2008) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. doi:10.1111/j.1365-313X.2008.03702.x
58. Patel J, Zhu H, Menassa R, Gyenis L, Richman A, Brandle J (2007) Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves. Transgenic Res 16:239-249. doi:10.1007/s11248-006-9026-2
59. Peng B, Robert-Guroff M (2001) Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation. Immunol Lett 78:195-200. doi:10.1016/S0165-2478(01)00250-4
60. Peng B, Voltan R, Cristillo AD, Alvord WG, Davis-Warren A, Zhou Q, Murthy KK, Robert-Guroff M (2006) Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity. AIDS 20:2149-2157. doi:10.1097/QAD.0b013e32801086ee
61. Porta C, Spall VE, Loveland J, Johnson JE, Barker PJ, Lomonossoff GP (1994) Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology 202:949-955. doi:10.1006/viro.1994.1417
62. Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, Quendler H, Stiegler G, Kunert R, Fischer R, Stoger E (2008) Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 6:189-201. doi:10.1111/j.1467-7652.2007.00306.x
63. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, Labrou N, Altmann F, Ma J, Stöger E, Capell T, Christou P (2008) Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 105:3727-3732. doi:10.1073/pnas.0708841104
64. Ramírez YJ, Tasciotti E, Gutierrez-Ortega A, Donayre Torres AJ, Olivera Flores MT, Giacca M, Gómez Lim MA (2007) Fruit-specific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice. Clin Vaccine Immunol 6:685-692. doi:10.1128/CVI.00028-07
65. Roeth JF, Collina KL (2006) Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 70:548-563. doi:10.1128/MMBR.00042-05
66. Ruf S, Karcher D, Bock R (2007) Determining the transgene containment level provided by chloroplast transformation. Proc Natl Acad Sci USA 104:6998-7002. doi:10.1073/pnas.0700008104
67. Sack M, Paetz A, Kunert R, Bomble M, Hesse F, Stiegler G, Fischer R, Katinger H, Stoeger E, Rademacher T (2007) Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures. FASEB J 21:1655-1664. doi:10.1096/fj.06-5863com
68. Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H (2007) Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 5:657-663. doi:10.1111/j.1467-7652.2007.00273.x
69. Schillberg S, Twyman RM, Fischer R (2005) Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine 23:1764-1769. doi:10.1016/j.vaccine.2004.11.002
70. Shewry PR, Napier JA, Tatham AS (1995) Seed storage proteins: structures and biosynthesis. Plant Cell 7:945-956
71. Sinclair E, Barbosa P, Feinberg MB (1997) The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable. J Virol 71:3641-3651
72. Sirén N, Weegar J, Dahlbacka J, Kalkkinen N, Fagervik K, Leisola M, vonWeymarn N (2006) Production of recombinant HIV-1 Nef (negative factor) protein using Pichia pastoris and a low-temperature fed-batch strategy. Biotechnol Appl Biochem 44:151-158. doi:10.1042/BA20060001
73. Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, Mach L, Glössl J, Weterings K, Pabst M, Steinkellner H (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6:392-402. doi:10.1111/j.1467-7652.2008.00330.x
74. Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5:2-15. doi:10.1111/j.1467-7652.2006.00216.x
75. Sugiyama Y, Hamamoto H, Takemoto S, Watanabe Y, Okada Y (1995) Systemic production of foreign peptides on the particle surface of tobacco mosaic virus. FEBS Lett 359:247-250. doi:10.1016/0014-5793(95)00054-D
76. Svab Z, Maliga P (2007) Exceptional transmission of plastids and mitochondria from the transplastomic pollen parent and its impact on transgene containment. Proc Natl Acad Sci USA 104:7003-7008. doi:10.1073/pnas.0700063104
77. Titti F, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Robert-Guroff M, Barnett S, Ensoli B (2007) Problems and emerging approaches in HIV/AIDS vaccine development. Expert Opin Emerg Drugs 12:23-48. doi:10.1517/14728214.12.1.23
78. Tobiume M, Takahoko M, Yamada T, Tatsumi M, Iwamoto A, Matsuda M (2002) Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. J Virol 76:5959-5965. doi:10.1128/JVI.76.12.5959-5965.2002
79. Triguero A, Cabrera G, Cremata JA, Yuen CT, Wheeler J, Ramírez NI (2005) Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans. Plant Biotechnol J 3:449-457. doi:10.1111/j.1467-7652.2005.00137.x
80. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70:1100-1108
81. Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, Weber R, Stiegler G, Vcelar B, Katinger H, Aceto L, Günthard HF (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11:615-622. doi:10.1038/nm1244
82. Trkola A, Kuster H, Rusert P, von Wyl V, Leemann C, Weber R, Stiegler G, Katinger H, Joos B, Günthard HF (2008) In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers. J Virol 82:1591-1599. doi:10.1128/JVI.01792-07
83. Vitale A, Boston RS (2008) Endoplasmic reticulum quality control and the unfolded protein response: insights from plants. Traffic 9:1581-1588. doi:10.1111/j.1600-0854.2008.00780.x
84. Vitale A, Denecke J (1999) The endoplasmic reticulum-gateway of the secretory pathway. Plant Cell 11:615-628
85. Voss G, Manson K, Montefiori D, Watkins DI, Heeney J, Wyand M, Cohen J, Bruck C (2003) Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine. J Virol 77:1049-1058. doi:10.1128/JVI.77.2.1049-1058.2003
86. Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320:760-764. doi:10.1126/science.1152622
87. Wandelt CI, Khan MR, Craig S, Schroeder HE, Spencer D, Higgins TJ (1992) Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J 2:181-192
88. Webster DE, Thomas MC, Pickering R, Whyte A, Dry IB, Gorry PR, Wesselingh SL (2005) Is there a role for plant-made vaccines in the prevention of HIV/AIDS? Immunol Cell Biol 83:239-247. doi:10.1111/j.1440-1711.2005.01341.x
89. Yang L, Suzuki K, Hirose S, Wakasa Y, Takaiwa F (2007) Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Plant Biotechnol J 5:815-826. doi:10.1111/j.1467-7652.2007.00287.x
90. Yu G, Felsted RL (1992) Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187:46-55. doi:10.1016/0042-6822(92)90293-X
91. Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, Koprowski H (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA 94:5784-5788. doi:10.1073/pnas.94.11.5784
92. Zhang G, Leung C, Murdin L, Rovinski B, White KA (2000) In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. Mol Biotechnol 14:99-107. doi:10.1385/MB:14:2:99
93. Zhang G, Rodrigues L, Rovinski B, White KA (2002) Production of HIV-1 p24 protein in transgenic tobacco plants. Mol Biotechnol 20:131-136. doi:10.1385/MB:20:2:131
94. Zhou F, Badillo-Corona JA, Karcher D, Gonzalez-Rabade N, Piepenburg K, Borchers A-MI, Maloney AP, Kavanagh TA, Gray JC, Bock R (2008) High-level expression of HIV antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 6:897-913. doi:10.1111/j.1467-7652.2008.00356.x
95. Zolla-Pazner S (2004) Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol 4:199-210